Posts Tagged: "Congress"

International Perspectives: R&D and AI Policies in the Global Landscape

Everyone’s talking about artificial intelligence (AI), but not everyone’s talking about it the same way. The tenor of the global conversation on AI ranges from dystopian fearmongering to evangelistic optimism. It’s vital to know the prevailing mood in the territory where you plan to launch your AI-powered service, app, or consultancy. In this article, we’ll briefly tour recent legislation, ethical conversations, and economic strategies to demonstrate how varied current thinking is on this revolutionary new technology. We’ll look at the current situation in the United States, Canada, Europe, China, Japan and beyond, as countries develop the policies, guidelines and laws necessary to regulate AI innovation without stifling creativity.

AI Voice Cloning – and Its Misuse – Has Opened a Pandora’s Box of Legal Issues: Here’s What to Know

Voice cloning, a technology that enables the replication of human voices from large language models using artificial intelligence (AI), presents both exciting possibilities and legal challenges. Recent machine-learning advances have made it possible for people’s voices to be imitated with only a few short seconds of a voice sample as training data. It’s a development that brings exciting possibilities for personalized and immersive experiences, such as creating realistic voiceovers for content, lifelike personal assistants and even preserving the voices of loved ones for future generations. But it’s also ripe with potential for abuse, as it could easily be used to commit fraud, spread misinformation and generate fake audio evidence.

This Week in Washington IP: How to Protect IP in Southeast Asia, Promoting Women in STEM, and Preventing Bank Failures

This week in Washington IP news, while Congress continues its summer recess, the U.S. Patent and Trademark Office (USPTO) hosts several events, including on how to protect your IP in Southeast Asia. The Office also continues its #WEWednesday series, this week with an installment on how to increase the number of women in the STEM field. Elsewhere, the Peterson Institute for International Economics will look at what preventative policy measures are needed to prevent repeat bank failures in the United States.

Gilead Wins Injunction in Counterfeit HIV Meds Case as Coons Recognizes August as National Anticounterfeiting Month

The U.S. District Court for the Eastern District of New York, in a decision published Monday, denied the defendants’ motions to vacate asset freezes in a case brought by Gilead alleging a massive HIV drug counterfeiting ring that involves “hundreds of millions of dollars’ worth” of fake medications. In January 2022, the court unsealed documents in the suit against a slew of defendants who Gilead said sold, marketed, and distributed counterfeits of its HIV medications. Gilead’s complaint sought immediate monetary and injunctive relief, including seizure at certain of the defendants’ premises, as well as relief for trademark and trade dress infringement and trademark dilution, among other alleged violations.

Vidal Tells Senate IP Subcommittee There Will Be Movement on ANPRM Proposals Soon

The Senate Subcommittee on Intellectual Property today held a hearing on Oversight of the United States Patent and Trademark Office (USPTO), with USPTO Director Kathi Vidal as the sole witness. Only a handful of senators questioned Vidal, and only one significantly challenged her in questioning. The hearing differed considerably from the House IP Subcommittee’s Oversight Hearing in April, where Vidal was repeatedly taken to task on the Office’s then-recently issued Advance Notice of Proposed Rulemaking (ANPRM).